Rep. Lisa C. McClain Sells Off Shares of Encompass Health Corporation (NYSE:EHC)

Representative Lisa C. McClain (R-Michigan) recently sold shares of Encompass Health Corporation (NYSE:EHC). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Encompass Health stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Encompass Health Stock Performance

Encompass Health stock traded down $0.03 on Friday, hitting $116.22. The company’s stock had a trading volume of 267,941 shares, compared to its average volume of 787,015. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The company has a fifty day moving average price of $120.62 and a 200-day moving average price of $119.51. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.99. The firm has a market cap of $11.69 billion, a P/E ratio of 21.97, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The business had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 14.37%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on EHC shares. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Barclays raised their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, November 23rd. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $142.86.

Institutional Trading of Encompass Health

Large investors have recently added to or reduced their stakes in the company. Citizens National Bank Trust Department bought a new stake in Encompass Health in the 3rd quarter valued at $26,000. WPG Advisers LLC acquired a new stake in shares of Encompass Health during the 1st quarter worth $27,000. First Horizon Corp bought a new stake in shares of Encompass Health during the 3rd quarter worth approximately $34,000. Westside Investment Management Inc. increased its stake in Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after acquiring an additional 101 shares during the last quarter. Finally, Assetmark Inc. increased its stake in Encompass Health by 88.1% in the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after acquiring an additional 140 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.